Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Hims & Hers Health Inc shares valued at $536,424 were sold by Chi Michael on Jan 24 ’25. At $31.00 per share, Chi Michael sold 17,304 shares. The insider’s holdings dropped to 193,601 shares worth approximately $6.17 million following the completion of this transaction.
Also, Dudum Andrew sold 27,098 shares, netting a total of over 815,029 in proceeds. Following the sale of shares at $30.08 each, the insider now holds 27,918 shares.
Before that, Chi Michael had added 17,304 shares to its account. In a trade valued at $536,424, the Officer bought Hims & Hers Health Inc shares for $31.00 each.
As published in a research note from Citigroup on January 10, 2025, Hims & Hers Health Inc [HIMS] has been rated down from a Neutral to a Sell and the price target has been revised to $25 from $24. Analysts at BTIG Research started covering the stock with ‘”a Buy”‘ outlook in a report released in early January. As of December 17, 2024, Morgan Stanley has initiated its “an Overweight” rating for HIMS. Earlier on November 14, 2024, BofA Securities downgraded its rating. Their new recommendation was “an Underperform” for HIMS stock which previously was a “a Buy”.
Analyzing HIMS Stock Performance
During the last five days, there has been a surge of approximately 7.20%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 31.76%. Shares of the company reached a 52-week high of $32.73 on 01/28/25 and a 52-week low of $24.07 on 01/10/25. A 50-day SMA is recorded $28.19, while a 200-day SMA reached $20.77. Nevertheless, trading volume fell to 5.98 million shares from 7.68 million shares the previous day.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 31.08, which, if violated, would cause prices to drop to 30.29. In the upper region, resistance lies at 32.49. The next price resistance is at 33.11. RSI (Relative Strength Index) is 64.51 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.58, which suggests the price will increase in the coming days. Percent R is at 10.05%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.